Viewing StudyNCT00477815



Ignite Creation Date: 2024-05-05 @ 5:33 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00477815
Status: COMPLETED
Last Update Posted: 2018-05-14
First Post: 2007-05-23

Brief Title: Rituximab Yttrium Y 90 Ibritumomab Tiuxetan Melphalan and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma
Sponsor: Mayo Clinic
Organization: Mayo Clinic

Conditions & Keywords Data

Conditions:
Name
Multiple Myeloma and Plasma Cell Neoplasm
Keywords:
Name View
stage III multiple myeloma View
stage I multiple myeloma View
refractory multiple myeloma View
stage II multiple myeloma View